Clinical characteristics of discharged COVID‑19 patients with reappeared positive nucleic acid test
X. Hu, L. Ni, Y. Chen, L. Zhang, Z. Cheng
{"title":"Clinical characteristics of discharged COVID‑19 patients with reappeared positive nucleic acid test","authors":"X. Hu, L. Ni, Y. Chen, L. Zhang, Z. Cheng","doi":"10.14188/j.1671-8852.2020.0580","DOIUrl":null,"url":null,"abstract":"Objective: To investigate the incidence of reappearance of positive results of nucleic acid (NA) test in discharged COVID‑19 patients, and retrospectively evaluate and compare the clinical characteristics between reappeared NA‑positive group and NA‑negative group, so as to provide the decision‑making basis for the quarantine management, health monitoring, and epidemic prevention. Methods: A total of 188 cases of discharged COVID‑19 patients from 3 quarantine observation sites in Wuhan from February to March 2020 were divided into reappeared NA‑positive group and NA‑negative group, based on the NA test. Clinical characteristics including general information, symptoms, underlying diseases, severity of disease, steroid administration, duration of hospitalization, duration from the beginning of positive to negative and time of onset of reappearance of positive for NA test, were compared between the two groups. Results: Of the 188 cases, 30 cases (15.96%) reappeared positive for NA test, and onset of reappearance ranged from day 1 to day 16 since the last NA negative, with a median time of 5 days after onset. A total of 51 cases (32.28%) in NA‑negative group had underlying diseases, while 18 (60.0%) cases reappeared NA‑positive had underlying diseases, and the rate of underlying diseases showed significant difference between the two groups (P<0.01). However, there were no statistical differences in gender, age, and symptoms on admission, severity of disease, steroid administration, duration from the beginning of positive to negative for NA test between the two groups. Conclusion: Since COVID‑19 patients with underlying diseases showed higher incidence of reappearance of positive NA test, COVID‑19 patients after discharge need to strengthen for quarantine control, further continuous health monitoring, and re‑tests of SARS‑CoV‑2 nucleic acid. © 2021, Editorial Board of Medical Journal of Wuhan University. All right reserved.","PeriodicalId":35402,"journal":{"name":"武汉大学学报(医学版)","volume":"42 1","pages":"867-871"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"武汉大学学报(医学版)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14188/j.1671-8852.2020.0580","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2
Abstract
Objective: To investigate the incidence of reappearance of positive results of nucleic acid (NA) test in discharged COVID‑19 patients, and retrospectively evaluate and compare the clinical characteristics between reappeared NA‑positive group and NA‑negative group, so as to provide the decision‑making basis for the quarantine management, health monitoring, and epidemic prevention. Methods: A total of 188 cases of discharged COVID‑19 patients from 3 quarantine observation sites in Wuhan from February to March 2020 were divided into reappeared NA‑positive group and NA‑negative group, based on the NA test. Clinical characteristics including general information, symptoms, underlying diseases, severity of disease, steroid administration, duration of hospitalization, duration from the beginning of positive to negative and time of onset of reappearance of positive for NA test, were compared between the two groups. Results: Of the 188 cases, 30 cases (15.96%) reappeared positive for NA test, and onset of reappearance ranged from day 1 to day 16 since the last NA negative, with a median time of 5 days after onset. A total of 51 cases (32.28%) in NA‑negative group had underlying diseases, while 18 (60.0%) cases reappeared NA‑positive had underlying diseases, and the rate of underlying diseases showed significant difference between the two groups (P<0.01). However, there were no statistical differences in gender, age, and symptoms on admission, severity of disease, steroid administration, duration from the beginning of positive to negative for NA test between the two groups. Conclusion: Since COVID‑19 patients with underlying diseases showed higher incidence of reappearance of positive NA test, COVID‑19 patients after discharge need to strengthen for quarantine control, further continuous health monitoring, and re‑tests of SARS‑CoV‑2 nucleic acid. © 2021, Editorial Board of Medical Journal of Wuhan University. All right reserved.
核酸检测再次呈阳性的出院COVID - 19患者临床特征分析
目的:调查出院COVID - 19患者核酸检测阳性结果再次出现的发生率,回顾性评价和比较再次出现NA阳性组和NA阴性组的临床特点,为检疫管理、健康监测和防疫工作提供决策依据。方法:根据NA检测结果,将2020年2 - 3月武汉市3个隔离观察点188例出院的COVID - 19患者分为再出现NA阳性组和NA阴性组。比较两组患者的临床特征,包括一般资料、症状、基础疾病、疾病严重程度、类固醇给药、住院时间、NA试验开始呈阳性到阴性的持续时间和再次出现阳性的时间。结果:188例患者中,30例(15.96%)再次出现NA检测阳性,再起时间为上一次NA阴性后第1天至第16天,中位时间为发病后5天。NA阴性组有基础疾病51例(32.28%),NA阳性组有基础疾病18例(60.0%),两组间基础疾病发生率差异有统计学意义(P<0.01)。然而,两组患者在性别、年龄、入院时症状、疾病严重程度、类固醇给药、NA检测开始阳性到阴性持续时间等方面均无统计学差异。结论:有基础疾病的COVID - 19患者NA检测再次出现阳性的发生率较高,出院后需加强检疫控制,进一步持续健康监测,并重新进行SARS - CoV - 2核酸检测。©2021,武汉大学医学杂志编辑委员会。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。